Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cross-reactivity

Cross-reactivity

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Pathogenesis of ANCA-associated vasculitides in 2021: An update].

La Revue de medecine interne·2022

Same author

A descriptive study of IgG4-related disease in children and young adults.

Autoimmunity reviews·2022

Same author

Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitis.

European journal of internal medicine·2021

Same author

[Evaluation of a woman's care program after pre-eclampsia].

La Revue de medecine interne·2021

Same author

[Systemic Rosai-Dorfman-Destombes disease associated with a myelodysplastic syndrome. Efficacy of hematologic treatment].

La Revue de medecine interne·2021

Same author

[Cutaneous hypereosinophilia… Hypereosinophilic syndromes].

Annales de dermatologie et de venereologie·2020

Search research articles

Related Experiment Video

Updated: Sep 20, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

[Epstein-Barr Virus and systemic lupus: Which connections?]

A Enfrein¹, M Hamidou¹

¹Service de médecine interne, PHU3, CHU de Nantes, 1, Places Alexis-Ricordeau, 44093 Nantes, France.

La Revue De Medecine Interne

|June 7, 2022

Summary

Epstein-Barr Virus (EBV) infection may trigger Systemic Lupus Erythematosus (SLE) by impairing immune control and promoting autoreactive B cells. Lupus patients show higher EBV loads, suggesting a link between the virus and disease activity.

Keywords:

Epstein-Barr Virus Lupus systémique Pathophysiology Physiopathologie Systemic lupus

More Related Videos

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

Related Experiment Videos

Last Updated: Sep 20, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

Area of Science:

Immunology
Virology
Rheumatology

Background:

Systemic lupus erythematosus (SLE) is a complex autoimmune disease influenced by genetic and environmental factors.
Epstein-Barr Virus (EBV), a herpesvirus infecting B lymphocytes, is implicated in SLE pathogenesis.
EBV infection often precedes lupus onset, with impaired immune control and higher viral loads observed in patients.

Purpose of the Study:

To investigate the role of Epstein-Barr Virus (EBV) in the onset and activity of Systemic Lupus Erythematosus (SLE).
To explore the mechanisms by which EBV may contribute to lupus pathophysiology.

Main Methods:

Review of existing in vitro data and animal models.
Analysis of humoral and cellular immune responses to EBV in SLE patients.
Assessment of EBV viral loads and their correlation with disease activity.

Main Results:

EBV infection is frequently observed before SLE onset.
Lupus patients exhibit abnormal immune responses to EBV and impaired viral control.
Higher EBV blood viral loads are detected in SLE patients.
EBV appears to promote autoreactive B lymphocyte survival and interferon-alpha production, key in SLE.

Conclusions:

Epstein-Barr Virus (EBV) is a significant environmental factor potentially contributing to Systemic Lupus Erythematosus (SLE) development and activity.
EBV's role in promoting autoreactive B cells and interferon-alpha production highlights its pathogenic relevance in lupus.